SG Americas Securities LLC Buys 2,998,635 Shares of Kenvue Inc. $KVUE

SG Americas Securities LLC increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 3,889.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,075,723 shares of the company’s stock after acquiring an additional 2,998,635 shares during the period. SG Americas Securities LLC owned 0.16% of Kenvue worth $53,056,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in KVUE. MAI Capital Management lifted its holdings in Kenvue by 4.3% in the 2nd quarter. MAI Capital Management now owns 37,235 shares of the company’s stock worth $779,000 after purchasing an additional 1,529 shares during the last quarter. AlphaCore Capital LLC grew its holdings in Kenvue by 9.9% during the second quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after purchasing an additional 476 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in Kenvue by 20.6% during the second quarter. Coldstream Capital Management Inc. now owns 35,314 shares of the company’s stock valued at $739,000 after purchasing an additional 6,032 shares during the last quarter. Prudential Financial Inc. raised its position in shares of Kenvue by 10.6% in the second quarter. Prudential Financial Inc. now owns 1,141,438 shares of the company’s stock valued at $23,890,000 after purchasing an additional 109,762 shares during the period. Finally, Waterloo Capital L.P. lifted its stake in shares of Kenvue by 8.8% in the second quarter. Waterloo Capital L.P. now owns 27,744 shares of the company’s stock worth $581,000 after buying an additional 2,237 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently issued reports on KVUE shares. Barclays upped their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the stock from $23.00 to $18.00 in a report on Friday, January 30th. Argus raised shares of Kenvue to a “hold” rating in a research report on Friday, March 6th. Canaccord Genuity Group upped their price target on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Finally, Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $19.58.

Kenvue Trading Down 0.4%

Shares of KVUE stock opened at $17.53 on Wednesday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The firm’s fifty day simple moving average is $17.99 and its 200 day simple moving average is $17.14. The firm has a market capitalization of $33.59 billion, a P/E ratio of 22.76, a price-to-earnings-growth ratio of 4.00 and a beta of 0.51. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.26 EPS. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. Kenvue’s dividend payout ratio is currently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.